Profile data is unavailable for this security.
About the company
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.
- Revenue in USD (TTM)644.12m
- Net income in USD-77.73m
- Incorporated1998
- Employees2.10k
- LocationNeogenomics Inc9490 Neogenomics WayFORT MYERS 33912United StatesUSA
- Phone+1 (239) 768-0600
- Fax+1 (775) 329-0852
- Websitehttps://neogenomics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pediatrix Medical Group Inc | 2.01bn | -253.84m | 1.27bn | 2.90k | -- | 1.73 | -- | 0.6312 | -3.07 | -3.07 | 24.07 | 8.53 | 0.9116 | -- | 7.11 | 692,068.30 | -11.53 | 0.8579 | -13.80 | 0.9945 | -- | -- | -12.65 | 1.52 | -- | 4.84 | 0.4611 | 0.00 | 1.15 | 2.97 | -196.55 | -- | 14.25 | -- |
| Progyny Inc | 1.14bn | 57.27m | 1.35bn | 563.00 | 25.81 | 3.04 | 22.44 | 1.19 | 0.5801 | 0.5801 | 11.57 | 4.92 | 1.64 | -- | 4.14 | 2,022,611.00 | 8.26 | 11.50 | 11.63 | 16.02 | 21.68 | 21.48 | 5.03 | 6.64 | -- | -- | 0.00 | 0.00 | 38.34 | 59.52 | 104.35 | -- | 44.47 | -- |
| US Physical Therapy Inc | 645.70m | 14.10m | 1.46bn | 3.90k | 103.66 | 3.03 | 29.91 | 2.27 | 0.9352 | 0.9352 | 42.93 | 32.02 | 0.6332 | -- | 8.70 | 165,606.30 | 3.12 | 7.13 | 4.31 | 10.64 | 19.41 | 21.96 | 4.93 | 9.71 | -- | 45.42 | 0.1753 | 58.53 | 9.34 | 5.91 | -38.01 | 1.78 | 5.26 | 13.33 |
| Clover Health Investments Corp | 1.54bn | -95.26m | 1.68bn | 552.00 | -- | 4.91 | -- | 1.09 | -0.1961 | -0.1882 | 3.16 | 0.6839 | 1.80 | -- | 8.38 | 2,797,861.00 | -11.12 | -- | -26.66 | -- | -- | -- | -6.17 | -- | -- | -13.53 | 0.00 | -- | -41.50 | -- | 37.03 | -- | -- | -- |
| Teladoc Health Inc | 2.59bn | -981.73m | 1.79bn | 5.60k | -- | 1.19 | -- | 0.6914 | -5.78 | -5.78 | 15.33 | 8.77 | 0.6592 | 20.73 | 12.39 | 462,430.30 | -24.99 | -33.54 | -30.10 | -34.63 | 70.82 | 68.59 | -37.91 | -171.39 | 1.69 | -- | 0.5055 | -- | 8.13 | 44.16 | 98.39 | -- | 79.43 | -- |
| National HealthCare Corporation | 1.24bn | 124.25m | 1.94bn | 13.12k | 15.77 | 1.98 | 11.68 | 1.57 | 7.98 | 7.98 | 79.63 | 63.69 | 0.8711 | 100.33 | 10.71 | 94,410.27 | 8.72 | 5.12 | 10.39 | 6.21 | 38.40 | 39.84 | 10.01 | 6.28 | 1.77 | -- | 0.1297 | 49.35 | 5.14 | 3.09 | 197.61 | 2.03 | -1.29 | 3.43 |
| NeoGenomics, Inc. | 644.12m | -77.73m | 1.98bn | 2.10k | -- | 2.17 | -- | 3.07 | -0.6152 | -0.6152 | 5.10 | 7.09 | 0.3881 | 14.99 | 4.53 | 306,722.80 | -4.68 | -3.57 | -5.31 | -3.80 | 43.54 | 41.09 | -12.07 | -9.36 | 1.91 | -- | 0.373 | -- | 16.07 | 16.41 | 39.02 | -- | 14.98 | -- |
| GeneDx Holdings Corp | 267.23m | -83.50m | 1.98bn | 1.00k | -- | 9.67 | -- | 7.41 | -3.17 | -3.17 | 10.11 | 7.45 | 0.6469 | 10.76 | 7.62 | 267,228.00 | -20.21 | -- | -24.54 | -- | 59.48 | 11.50 | -31.25 | -121.10 | 2.27 | -3.72 | 0.2028 | -- | -13.69 | 8.72 | 67.98 | -- | 7.77 | -- |
| Addus Homecare Corporation | 1.13bn | 73.65m | 2.19bn | 6.06k | 27.67 | 2.31 | 25.00 | 1.93 | 4.37 | 4.37 | 67.24 | 52.26 | 1.04 | -- | 10.42 | 187,127.60 | 6.73 | 5.18 | 7.79 | 6.04 | 32.15 | 30.88 | 6.50 | 4.96 | -- | 19.47 | 0.00 | 0.00 | 11.31 | 15.43 | 35.83 | 30.83 | 12.06 | -- |
| Ardent Health Partners Inc | 5.71bn | 106.92m | 2.26bn | 24.20k | 20.70 | 2.24 | 7.18 | 0.3953 | 0.7631 | 0.7631 | 40.72 | 7.05 | -- | -- | -- | -- | -- | -- | -- | -- | 56.55 | -- | 2.97 | -- | 1.78 | 3.89 | 0.4414 | -- | 5.45 | -- | -71.47 | -- | -- | -- |
| Alignment Healthcare Inc | 2.47bn | -144.15m | 2.32bn | 1.54k | -- | 20.24 | -- | 0.94 | -0.7606 | -0.7606 | 12.99 | 0.5979 | 3.37 | -- | 20.20 | 1,606,580.00 | -19.72 | -- | -41.65 | -- | 10.45 | -- | -5.85 | -- | -- | -4.96 | 0.6471 | -- | 27.16 | -- | 1.02 | -- | -- | -- |
| Astrana Health Inc | 1.72bn | 62.46m | 2.37bn | 1.80k | 32.23 | 2.86 | 28.78 | 1.38 | 1.31 | 1.31 | 36.06 | 14.75 | 1.46 | -- | 8.80 | 956,870.60 | 4.89 | 7.09 | 5.71 | 9.39 | 15.09 | 18.30 | 3.35 | 6.36 | -- | 9.20 | 0.4642 | 10.54 | 21.19 | 21.68 | 34.42 | 41.16 | 89.42 | -- |
| Privia Health Group Inc | 1.72bn | 12.82m | 2.53bn | 1.10k | 205.90 | 4.11 | 119.27 | 1.47 | 0.1024 | 0.1024 | 13.71 | 5.13 | 1.61 | -- | 4.52 | 1,557,457.00 | 1.31 | -- | 2.39 | -- | 9.78 | 9.15 | 0.8158 | -2.56 | -- | -- | 0.00 | -- | 22.19 | 20.31 | 368.83 | -- | -12.48 | -- |
| PACS Group Inc | -100.00bn | -100.00bn | 2.57bn | 32.43k | -- | 4.41 | -- | -- | -- | -- | -- | 3.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.4792 | -- | 28.47 | -- | -25.00 | -- | -- | -- |
| Concentra Group Holdings Parent Inc | 1.88bn | 172.87m | 2.74bn | 8.90k | 14.60 | 9.85 | 11.03 | 1.46 | 1.47 | 1.47 | 15.70 | 2.18 | -- | -- | -- | 210,774.30 | -- | -- | -- | -- | 27.59 | -- | 9.49 | -- | -- | 5.16 | 0.8311 | -- | 6.60 | -- | 7.93 | -- | -- | -- |
| Lifestance Health Group Inc | 1.21bn | -95.29m | 2.80bn | 7.27k | -- | 1.95 | -- | 2.32 | -0.2536 | -0.2536 | 3.20 | 3.76 | 0.5632 | -- | 7.83 | 129,339.70 | -4.45 | -- | -4.98 | -- | -- | -- | -7.90 | -- | -- | -2.32 | 0.164 | -- | 22.82 | -- | 13.59 | -- | -- | -- |
Data as of Nov 21 2024. Currency figures normalised to Neogenomics Inc's reporting currency: US Dollar USD
56.78%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2024 | 18.42m | 14.38% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 13.81m | 10.77% |
| Brown Advisory LLCas of 30 Sep 2024 | 6.89m | 5.37% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2024 | 6.54m | 5.10% |
| Janus Henderson Investors US LLCas of 30 Sep 2024 | 6.53m | 5.10% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 4.96m | 3.87% |
| Greenhouse Funds LLLPas of 30 Sep 2024 | 4.46m | 3.48% |
| Schroder Investment Management North America, Inc.as of 30 Sep 2024 | 4.22m | 3.29% |
| Macquarie Investment Management Business Trustas of 30 Sep 2024 | 3.82m | 2.98% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 3.11m | 2.43% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
